ACCESS Newswire

New Book Release: 'The Dyslexic Edge' by the Dyslexic Entrepreneur, Jamie Waller, and the Dyslexic Professor, Dr. Helen Taylor

Share

40% of self-made millionaires and 35% of entrepreneurs are dyslexic

LONDON, UK / ACCESSWIRE / September 9, 2024 / Esteemed entrepreneur Jamie Waller, known as "The Dyslexic Entrepreneur," together with leading dyslexia expert Dr. Helen Taylor, is proud to announce the release of their transformative new book, The Dyslexic Edge. This highly anticipated book, available globally on September 12th, unveils the secrets behind why dyslexic thinkers excel in business and often become self-made millionaires.

The Dyslexic Edge delves into the extraordinary lives of some of the world's most successful dyslexic entrepreneurs, offering a unique perspective on how dyslexia can be a powerful asset in the business world. This book may be the first of its kind-written by dyslexics, for dyslexics, and for anyone looking to harness the advantages of dyslexia to boost their career or entrepreneurial journey.

The book features compelling interviews with 14 influential dyslexics, including:

  • Sir Charles Dunstone, the mastermind behind Carphone Warehouse and Five Guys in the UK.

  • Paul Orfalea, founder of Kinko's and a U.S. print billionaire.

  • Kelly Hoppen, the renowned interior designer to David Beckham.

  • Duncan Bannatyne and Theo Paphitis, both well-known investors and TV personalities from Dragon's Den.

  • Kate Griggs, founder of Made By Dyslexia and an advocate for the dyslexic community.

Sir Richard Branson, arguably the most famous dyslexic entrepreneur, planted the seed during a conversation with Jamie Waller on Necker Island in 2023, and it is now available for pre-order and a few days from release.

One of the most eye-opening aspects of The Dyslexic Edge is its exploration of the statistics: 40% of self-made millionaires and 35% of entrepreneurs are dyslexic. The book addresses a crucial question: What is it about dyslexia that makes dyslexic thinkers great at becoming rich? Jamie Waller and Dr. Helen Taylor uncover these secrets and share them with readers, providing valuable insights into how dyslexic traits such as creative problem-solving, resilience, and innovative thinking contribute to exceptional success.

"By telling these stories, we hope to inspire others with dyslexia to recognise their condition not as a barrier but as a unique strength that can lead to incredible success," said Jamie Waller.

Co-author Dr. Helen Taylor brings her academic expertise to the table, ensuring that the narratives are not only inspiring but also backed by research on the strengths associated with dyslexia.

The Dyslexic Edge is available in all formats and will be sold worldwide, making it accessible to a broad audience eager to learn how dyslexia can be leveraged for extraordinary success.

For more information about the book or to schedule an interview with Jamie Waller or Dr. Helen Taylor, please contact jw@jamiewaller.co.uk or 07779 714 390.

About the Authors:

Jamie Waller is an entrepreneur, author, and advocate known as "The Dyslexic Entrepreneur." He has founded and sold several successful businesses and now dedicates his time to helping others realise their potential, having set up The Prince's Trust Enterprise Network in 2021.

Dr. Helen Taylor is a respected academic specialising in the strengths and advantages of dyslexia. She has published extensively on the topic and is passionate about helping dyslexics leverage their unique abilities.

Contact Information:

Jamie Waller
The Dyslexic Entrepreneur
jw@jamiewaller.co.uk
07779714390

Related Files

Jamie Waller Media

SOURCE: The Dyslexic Entrepreneur

View the original press release on newswire.com.

The Dyslexic Entrepreneur

Subscribe to releases from ACCESS Newswire

Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from ACCESS Newswire

OBI-902 Has Been Granted by US FDA for Orphan Drug Designation for the Treatment of Cholangiocarcinoma17.11.2025 13:00:00 CET | Press release

OBI-902 is the first ADC utilizing OBI's proprietary GlycOBI® glycan-based ADC enabling technology for evaluation of safety and efficacy in patients with Cancer. TAIPEI, TW / ACCESS Newswire / November 17, 2025 / OBI Pharma, a clinical-stage oncology company (4174.TWO) received notification from the US FDA stating that the request for Orphan Drug Designation of OBI-902 TROP2 ADC for the treatment of Cholangiocarcinoma has been granted. OBI-902 is the first OBI-developed ADC that incorporates our proprietary site-specific glycan-conjugated ADC enabling technology. Cholangiocarcinoma is a rare and lethal malignancy with fewer than 50,000 patients in the United States and a 5-year survival rate ranging from 2% and 23% depending on disease stage, histological subtype, and localization 1 . At present, there are no FDA approved ADC therapies for cholangiocarcinoma. To encourage the industry to develop new treatment options for rare diseases, the US FDA grants Orphan Drug Designation to exper

Camino Completes C$5.6 Million Investment with Strategic Investors17.11.2025 12:00:00 CET | Press release

VANCOUVER, BC / ACCESS Newswire / November 17, 2025 / Camino Minerals Corporation (TSXV:COR)(OTC:CAMZF) ("Camino" or the "Company") is pleased to announce the closing of its -brokered private placement (the "Financing") of common shares in the capital of the Company (the "Shares") previously announced in its news release dated November 12, 2025. Under the Financing, the Company issued an aggregate of 15,554,666 Shares at an issue price of $0.36 per Share, for aggregate gross proceeds of C$5,599,680. Participants in the Financing included two new key shareholders, Elemental Royalties (formerly EMX Royalty Corp.) and Continental General Insurance Company, as well as certain insiders of Camino. The gross proceeds of the Financing will be applied towards corporate working capital, legal expenses, engineering studies, project development, and general administrative expenses. The Shares issued pursuant to the Financing are subject to a statutory hold period expiring on March 15, 2026, in acc

GA-ASI Completes Full-Scale Fatigue Test on MQ-9B17.11.2025 03:10:00 CET | Press release

MQ-9B's Third Lifetime Test Completes the FSF Testing Process With a Total of 120,000 Hours DUBAI, UAE / ACCESS Newswire / November 16, 2025 / On October 31, 2025, General Atomics Aeronautical Systems, Inc. (GA-ASI) completed its "third lifetime" of full-scale fatigue (FSF) testing for the MQ-9B Remotely Piloted Aircraft (RPA). Completion of FSF testing for the third and final lifetime includes a total of 120,000 operating hours (40,000+ flight hours per aircraft life) for the RPA and is a key milestone in validating the design of the airframe. The testing verifies the airframe structural integrity in support of certification to the NATO STANAG 4671 standard. The aim of the testing is to identify any potential structural deficiencies ahead of fleet usage and assist in developing inspection and maintenance schedules for the airframe. Test results will be used as documentation for certification and will form the basis for in-service inspections of structural components. "The completion o

GA-ASI and Saab Will Demonstrate AEW&C on MQ-9B in 202617.11.2025 03:05:00 CET | Press release

Two Aerospace Leaders Are Bringing Airborne Early Warning and Control to UAS DUBAI, UAE / ACCESS Newswire / November 16, 2025 / Following their announcement to bring Airborne Early Warning and Control (AEW&C) capability to the world's leading Remotely Piloted Aircraft (RPA) platform, General Atomics Aeronautical Systems, Inc. (GA-ASI) and Saab will now team up to demonstrate the capability in the summer of 2026. The demo will be conducted at GA-ASI's Desert Horizon flight operations facility in Southern California using a GA-ASI MQ-9B equipped with AEW&C supplied by Saab. In partnership with Saab, a leading company in AEW&C systems, GA-ASI is pairing Saab's AEW sensors with the world's longest-range, highest-endurance RPA, the MQ-9B. At sea or over land, adding AEW capabilities on MQ-9B enables persistent air surveillance and enables AEW in areas of the world where it doesn't currently exist or is unaffordable, such as for navy aircraft carriers at sea. "Adding AEW&C to the MQ-9B bring

Doha Tattoo Festival Announced as Ticket Sales Officially Open16.11.2025 12:45:00 CET | Press release

DOHA, QA / ACCESS Newswire / November 16, 2025 / Under the patronage of His Excellency Sheikh Khalifa bin Hamad bin Khalifa Al Thani, Minister of Interior and Commander of the Internal Security Force (Lekhwiya), the first edition of the Doha International Music and Marching Festival (Doha Tattoo) will be held from 16 to 20 December 2025 at Katara Cultural Village. A press conference held at Katara Cultural Village unveiled the line-up of participating bands and ticket details, attended by members of the Doha Tattoo organising committee and partner representatives. The Doha Tattoo will combine precision with musical artistry, showcasing performances by distinguished musical bands from seven countries: the United Kingdom, the United States of America, Turkia, Hashemite Kingdom of Jordan , the Sultanate of Oman, Kazakhstan, and the State of Qatar. The participating line-up includes the Irish Guards and the Royal Air Force Music Services from the United Kingdom, the United States Air Force

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye